nach oben

Erschienen in:

22.06.2019 | Original Contribution

The combination of wheat peptides and fucoidan protects against chronic superficial gastritis and alters gut microbiota: a double-blinded, placebo-controlled study

verfasst von: Juntao Kan, Junrui Cheng, Leiming Xu, Molly Hood, Dingfu Zhong, Meijiao Cheng, Yumin Liu, Liang Chen, Jun Du

Erschienen in: European Journal of Nutrition | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Chronic gastritis is observed in almost half world population. Traditional medications against chronic gastritis might produce adverse effects, so alternative nutritional strategies are needed to prevent the aggravation of gastric mucosal damage. The aim of this study is to evaluate the protective effect of the combination of wheat peptides and fucoidan (WPF) on adults diagnosed with chronic superficial gastritis in a randomized, double-blind, placebo-controlled clinical trial.

Methods

Participants were randomized to receive WPF (N = 53) or placebo (N = 53) once daily for 45 days. Pathological grading of gastric mucosal damage was scored using gastroscopy. Fecal samples were collected for the determination of calprotectin, short chain fatty acids (SCFA) levels and metagenomics analysis. Questionnaires for self-reported gastrointestinal discomforts, life quality and food frequency were collected throughout the study.

Results

WPF intervention reduced gastric mucosal damage in 70% subjects (P < 0.001). Significantly less stomach pain (P < 0.001), belching (P = 0.028), bloating (P < 0.001), acid reflux (P < 0.001), loss of appetite (P = 0.021), increased food intake (P = 0.020), and promoted life quality (P = 0.014) were reported in the WPF group. WPF intervention significantly decreased fecal calprotectin level (P = 0.003) while slightly increased fecal SCFAs level (P = 0.092). In addition, we found altered microbiota composition post-intervention with increased Bifidobacterium pseudocatenulatum (P = 0.032), Eubacterium siraeum (P = 0.036), Bacteroides intestinalis (P = 0.024) and decreased Prevotella copri (P = 0.055).

Conclusions

WPF intervention could be utilized as a nutritional alternative to mitigate the progression of chronic gastritis. Furthermore, WPF played an important role in altering gut microbial profile and SCFA production, which might benefit the lower gastrointestinal tract.

Nur mit Berechtigung zugänglich

Du Y, Bai Y, Xie P, Fang J, Wang X, Hou X, Tian D, Wang C, Liu Y, Sha W, Wang B, Li Y, Zhang G, Li Y, Shi R, Xu J, Li Y, Huang M, Han S, Liu J, Ren X, Xie P, Wang Z, Cui L, Sheng J, Luo H, Wang Z, Zhao X, Dai N, Nie Y, Zou Y, Xia B, Fan Z, Chen Z, Lin S, Li ZS (2014) Chronic gastritis in China: a national multi-center survey. BMC Gastroenterol 14:21. https://doi.org/10.1186/1471-230x-14-21 CrossRefPubMedPubMedCentral

Sipponen P, Maaroos HI (2015) Chronic gastritis. Scand J Gastroenterol 50(6):657–667. https://doi.org/10.3109/00365521.2015.1019918 CrossRefPubMedPubMedCentral

Ddine LC, Ddine CC, Rodrigues CC, Kirsten VR, Colpo E (2012) Factors associated with chronic gastritis in patients with presence and absence of Helicobacter pylori. Arq Bras Cir Dig 25(2):96–100PubMedCrossRef

Correa P, Yardley JH (1992) Grading and classification of chronic gastritis: one American response to the Sydney system. Gastroenterology 102(1):355–359PubMedCrossRef

Siurala M, Sipponen P, Kekki M (1985) Chronic gastritis: dynamic and clinical aspects. Scand J Gastroenterol Suppl 109:69–76PubMedCrossRef

Brenner H, Rothenbacher D, Arndt V (2009) Epidemiology of stomach cancer. Methods Mol Biol 472:467–477. https://doi.org/10.1007/978-1-60327-492-0_23 CrossRefPubMed

Sipponen P, Price AB (2011) The Sydney System for classification of gastritis 20 years ago. J Gastroenterol Hepatol 26(Suppl 1):31–34. https://doi.org/10.1111/j.1440-1746.2010.06536.x CrossRefPubMed

Helicobacter A (2001) Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49(3):347–353CrossRef

Vorobjova T, Faller G, Maaroos HI, Sipponen P, Villako K, Uibo R, Kirchner T (2000) Significant increase in antigastric autoantibodies in a long-term follow-up study of H. pylori gastritis. Virchows Arch 437(1):37–45PubMedCrossRef

10.

Kan J, Hood M, Burns C, Scholten J, Chuang J, Tian F, Pan X, Du J, Gui M (2017) A novel combination of wheat peptides and fucoidan attenuates ethanol-induced gastric mucosal damage through anti-oxidant, anti-inflammatory, and pro-survival mechanisms. Nutrients 9(9):E978. https://doi.org/10.3390/nu9090978 CrossRefPubMed

11.

Kamada N, Seo SU, Chen GY, Núñez G (2013) Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 13(5):321–335PubMedCrossRef

12.

Kostic AD, Xavier RJ, Gevers D (2014) The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 146(6):1489–1499PubMedCrossRef

13.

Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME, Brezillon S, Dupriez V, Vassart G, Van Damme J, Parmentier M, Detheux M (2003) Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 278(28):25481–25489. https://doi.org/10.1074/jbc.M301403200 CrossRefPubMed

14.

Chambers ES, Preston T, Frost G, Morrison DJ (2018) Role of Gut microbiota-generated short-chain fatty acids in metabolic and cardiovascular health. Curr Nutr Rep. https://doi.org/10.1007/s13668-018-0248-8 CrossRefPubMedPubMedCentral

15.

Anand S, Mande SS (2018) Diet, microbiota and gut-lung connection. Front Microbiol 9:2147. https://doi.org/10.3389/fmicb.2018.02147 CrossRefPubMedPubMedCentral

16.

Sircana A, Framarin L, Leone N, Berrutti M, Castellino F, Parente R, De Michieli F, Paschetta E, Musso G (2018) Altered gut microbiota in type 2 diabetes: just a coincidence? Curr Diabetes Rep 18(10):98. https://doi.org/10.1007/s11892-018-1057-6 CrossRef

17.

Valle J, Seppala K, Sipponen P, Kosunen T (1991) Disappearance of gastritis after eradication of Helicobacter pylori. A morphometric study. Scand J Gastroenterol 26(10):1057–1065PubMedCrossRef

18.

Arkkila PE, Seppala K, Farkkila MA, Veijola L, Sipponen P (2006) Helicobacter pylori eradication in the healing of atrophic gastritis: a one-year prospective study. Scand J Gastroenterol 41(7):782–790. https://doi.org/10.1080/00365520500463175 CrossRefPubMed

19.

Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444(7122):1022–1023. https://doi.org/10.1038/4441022a CrossRefPubMed

20.

Couzin-Frankel J (2010) Bacteria and asthma: untangling the links. Science 330(6008):1168–1169. https://doi.org/10.1126/science.330.6008.1168 CrossRefPubMed

21.

Sekirov I, Russell SL, Antunes LC, Finlay BB (2010) Gut microbiota in health and disease. Physiol Rev 90(3):859–904. https://doi.org/10.1152/physrev.00045.2009 CrossRefPubMed

22.

Yin H, Pan X, Song Z, Wang S, Yang L, Sun G (2014) Protective effect of wheat peptides against indomethacin-induced oxidative stress in IEC-6 cells. Nutrients 6(2):564–574. https://doi.org/10.3390/nu6020564 CrossRefPubMedPubMedCentral

23.

Zhang QX, Ling YF, Sun Z, Zhang L, Yu HX, Kamau SM, Lu RR (2012) Protective effect of whey protein hydrolysates against hydrogen peroxide-induced oxidative stress on PC12 cells. Biotechnol Lett 34(11):2001–2006. https://doi.org/10.1007/s10529-012-1017-1 CrossRefPubMed

24.

Yang X, Wang Y, Wang F, Xia H, Pan X, Zhu H, Ruizeng GU, Yongqing MA, Tang H, Wang S (2016) Effect of hydrolyzed wheat protein peptide on ethanol-induced acute gastric mucosal damage in rats. Food Sci 37:178–182

25.

Hong Y, Pan XC, Wang SK, Yang LG, Sun GJ (2014) Protective effect of wheat peptides against small intestinal damage induced by non-steroidal anti-inflammatory drugs in rats. J Integr Agr 13(9):2019–2027CrossRef

26.

Wijesinghe WAJP, Jeon YJ (2012) Biological activities and potential industrial applications of fucose rich sulfated polysaccharides and fucoidans isolated from brown seaweeds: a review. Carbohydr Polym 88:13–20. https://doi.org/10.1016/j.carbpol.2011.12.029 CrossRef

27.

Cumashi A, Ushakova NA, Preobrazhenskaya ME, D’Incecco A, Piccoli A, Totani L, Tinari N, Morozevich GE, Berman AE, Bilan MI, Usov AI, Ustyuzhanina NE, Grachev AA, Sanderson CJ, Kelly M, Rabinovich GA, Iacobelli S, Nifantiev NE (2007) A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology 17(5):541–552. https://doi.org/10.1093/glycob/cwm014 CrossRefPubMed

28.

Yang C, Chung D, Shin IS, Lee H, Kim J, Lee Y, You S (2008) Effects of molecular weight and hydrolysis conditions on anticancer activity of fucoidans from sporophyll of Undaria pinnatifida. Int J Biol Macromol 43(5):433–437. https://doi.org/10.1016/j.ijbiomac.2008.08.006 CrossRefPubMed

29.

Drossman DA (2006) The functional gastrointestinal disorders and the Rome III process. Gastroenterology 130(5):1377–1390PubMedCrossRef

30.

Price AB (1991) The Sydney System: histological division. J Gastroenterol Hepatol 6(3):209–222PubMedCrossRef

31.

Dixon MF, Genta RM, Yardley JH, Correa P (1996) Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20(10):1161–1181PubMedCrossRef

32.

Yu Z (2004) Endoscopic classification and trial standards on treatment of chronic gastritis. Chin J Dig Endosc 21(2):77–78

33.

CFDA (2003) Method for the assessment of protection of gastric mucosa function. Technical Standards for Testing and Assessment for Health Food, pp 163–166

34.

Group TW (1995) The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 41(10):1403–1409CrossRef

35.

Waller PA, Gopal PK, Leyer GJ, Ouwehand AC, Reifer C, Stewart ME, Miller LE (2011) Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scand J Gastroenterol 46(9):1057PubMedPubMedCentralCrossRef

36.

Mei H, Sun J, Zhuo QJ, Yue XY (2017) Effects of cow’s milk beta-casein variants on symptoms of milk intolerance in Chinese adults: a multicentre, randomised controlled study. Nutr J 16(1):72CrossRef

37.

Zhao L, Zhang F, Ding X, Wu G, Lam YY, Wang X, Fu H, Xue X, Lu C, Ma J (2018) Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science 359(6380):1151–1156PubMedCrossRef

38.

Roat KJ, Pedro CL, Kristoffer F, Jaime HC, Li SS, Marja D, Yvonne VA, Georg Z, Shinichi S, Peer B (2016) MOCAT2: a metagenomic assembly, annotation and profiling framework. Bioinformatics 32(16):2520–2523CrossRef

39.

Li R, Yu C, Li Y, Lam TW, Yiu SM, Kristiansen K, Wang J (2009) SOAP2: an improved ultrafast tool for short read alignment. Bioinformatics 25(15):1966–1967PubMedCrossRef

40.

Fu L, Niu B, Zhu Z, Wu S, Li W (2012) CD-HIT: accelerated for clustering the next-generation sequencing data. Bioinformatics 28(23):3150–3152PubMedPubMedCentralCrossRef

41.

Truong DT, Franzosa EA, Tickle TL, Scholz M, Weingart G, Pasolli E, Tett A, Huttenhower C, Segata N (2015) MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat Methods 12(10):902PubMedCrossRef

42.

Sung J, Kim S, Cabatbat JJT, Jang S, Jin YS, Jung GY, Chia N, Kim PJ (2017) Global metabolic interaction network of the human gut microbiota for context-specific community-scale analysis. Nat Commun 8:15393PubMedPubMedCentralCrossRef

43.

François IE, Lescroart O, Veraverbeke WS, Marzorati M, Possemiers S, Evenepoel P, Hamer H, Houben E, Windey K, Welling GW (2012) Effects of a wheat bran extract containing arabinoxylan oligosaccharides on gastrointestinal health parameters in healthy adult human volunteers: a double-blind, randomised, placebo-controlled, cross-over trial. Br J Nutr 108(12):2229–2242PubMedCrossRef

44.

Benarye E, Goldin E, Wengrower D, Stamper A, Kohn R, Berry E (2002) Wheat grass juice in the treatment of active distal ulcerative colitis: a randomized double-blind placebo-controlled trial. Scand J Gastroenterol 37(4):444–449CrossRef

45.

Renaldi K, Simadibrata M, Syam AF, Rani AA, Krisnuhoni E (2011) Influence of fucoidan in mucus thickness of gastric mucosa in patients with chronic gastritis. Indones J Gastroenterol Hepatol Dig Endosc 12(2):79–84

46.

Raghavendran HRB, Srinivasan P, Rekha S (2011) Immunomodulatory activity of fucoidan against aspirin-induced gastric mucosal damage in rats. Int Immunopharmacol 11(2):157–163PubMedCrossRef

47.

Wang Y, Su W, Zhang C, Xue C, Chang Y, Wu X, Tang Q, Wang J (2012) Protective effect of sea cucumber (Acaudina molpadioides) fucoidan against ethanol-induced gastric damage. Food Chem 133(4):1414–1419CrossRef

48.

Shi H, Chang Y, Gao Y, Wang X, Chen X, Wang Y, Xue C, Tang Q (2017) Dietary fucoidan of Acaudina molpadioides alters gut microbiota and mitigates intestinal mucosal injury induced by cyclophosphamide. Food Funct 8(9):3383–3393PubMedCrossRef

49.

Shibata H, Iimuro M, Uchiya N, Kawamori T, Nagaoka M, Ueyama S, Hashimoto S, Yokokura T, Sugimura T, Wakabayashi K (2010) Preventive effects of cladosiphon fucoidan against Helicobacter pylori infection in Mongolian gerbils. Helicobacter 8(1):59–65CrossRef

50.

Besednova NN, Zaporozhets TS, Somova LM, Kuznetsova TA (2015) Prospects for the use of extracts and polysaccharides from marine algae to prevent and treat the diseases caused by Helicobacter pylori. Helicobacter 20(2):89–97PubMedCrossRef

51.

Simon P, Goode P, Mobasseri A, Zopf D (1997) Inhibition of Helicobacter pylori binding to gastrointestinal epithelial cells by sialic acid-containing oligosaccharides. Infect Immun 65(2):750–757PubMedPubMedCentralCrossRef

52.

Lehmann FS, Burri E, Beglinger C (2015) The role and utility of faecal markers in inflammatory bowel disease. Ther Adv Gastroenterol 8(1):23–36CrossRef

53.

Røseth AG, Schmidt PM, Fagerhol MK (1998) Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol 34(1):50–54

54.

Costa F, Mumolo MG, Ceccarelli L, Bellini M, Romano MR, Sterpi C, Ricchiuti A, Marchi S, Bottai M (2005) Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn’s disease. Gut 54(3):364–368PubMedPubMedCentralCrossRef

55.

Massimo Montalto, Antonella Gallo, Gianluca Ianiro, Luca Santoro, Ferruccio Onofrio (2010) Can chronic gastritis cause an increase in fecal calprotectin concentrations? World J Gastroenterol 16(27):3406CrossRef

56.

Summerton CB, Longlands MG, Wiener K, Shreeve DR (2002) Faecal calprotectin: a marker of inflammation throughout the intestinal tract. Eur J Gastroenterol Hepatol 14(8):841–845PubMedCrossRef

57.

Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125(6):1401–1412PubMedCrossRef

58.

Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB (2004) Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 17(2):259–275PubMedCrossRef

59.

Roberfroid MB (2000) Prebiotics and probiotics: are they functional foods?–. Am J Clin Nutr 71(6):1682S–1687SCrossRefPubMed

60.

Zaporozhets TS, Besednova NN, Kuznetsova TA, Zvyagintseva TN, Makarenkova ID, Kryzhanovsky SP, Melnikov VG (2014) The prebiotic potential of polysaccharides and extracts of seaweeds. Russ J Mar Biol 40(1):1–9CrossRef

61.

Shang Q, Shan X, Cai C, Hao J, Li G, Yu G (2016) Dietary fucoidan modulates the gut microbiota in mice by increasing the abundance of Lactobacillus and Ruminococcaceae. Food Funct 7(7):3224PubMedCrossRef

62.

Lynch MB, Sweeney T, Callan JJ, O’Sullivan JT, O’Doherty JV (2010) The effect of dietary Laminaria-derived laminarin and fucoidan on nutrient digestibility, nitrogen utilisation, intestinal microflora and volatile fatty acid concentration in pigs. J Sci Food Agric 133(1):157–160

63.

Wang Y, Han F, Hu B, Li J, Yu W (2006) In vivo prebiotic properties of alginate oligosaccharides prepared through enzymatic hydrolysis of alginate. Nutr Res 26(11):597–603CrossRef

64.

Shang Q, Song G, Zhang M, Shi J, Xu C, Hao J, Li G, Yu G (2017) Dietary fucoidan improves metabolic syndrome in association with increased Akkermansia population in the gut microbiota of high-fat diet-fed mice. J Funct Foods 28:138–146CrossRef

65.

Boffa LC, Lupton JR, Mariani MR, Ceppi M, Newmark HL, Scalmati A, Lipkin M (1992) Modulation of colonic epithelial cell proliferation, histone acetylation, and luminal short chain fatty acids by variation of dietary fiber (wheat bran) in rats. Cancer Res 52(21):5906–5912PubMed

66.

Neyrinck AM, Possemiers S, Druart C, Van TDW, De FB, Cani PD, Larondelle Y, Delzenne NM (2011) Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice. PLoS One 6(6):e20944PubMedPubMedCentralCrossRef

67.

Davila AM, Blachier F, Gotteland M, Andriamihaja M, Benetti PH, Sanz Y, Tomé D (2013) Intestinal luminal nitrogen metabolism: role of the gut microbiota and consequences for the host. Pharmacol Res 69(1):114–126PubMedCrossRef

68.

Caminero A, Nistal E, Arias L, Vivas S, Comino I, Real A, Sousa C, de Morales JM, Ferrero MA, Rodríguez-Aparicio LB (2012) A gluten metabolism study in healthy individuals shows the presence of faecal glutenasic activity. Eur J Nutr 51(3):293–299PubMedCrossRef

69.

De Palma G, Nadal I, Collado MC, Sanz Y (2009) Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects. Br J Nutr 102(8):1154–1160PubMedCrossRef

70.

Caminero A, Nistal E, Herrán AR, Pérez-Andrés J, Vaquero L, Vivas S, de Morales JMR, Casqueiro J (2014) Gluten metabolism in humans: involvement of the gut microbiota. In: Wheat and rice in disease prevention and health. Elsevier, pp 157–170. https://www.sciencedirect.com/science/article/pii/B9780124017160000131

71.

Caminero A, Nistal E, Herrán AR, Pérez-Andrés J, Ferrero MA, Ayala LV, Vivas S, de Morales JMR, Albillos SM, Casqueiro FJ (2015) Differences in gluten metabolism among healthy volunteers, coeliac disease patients and first-degree relatives. Br J Nutr 114(8):1157–1167PubMedCrossRef

72.

Laparra JM, Sanz Y (2010) Bifidobacteria inhibit the inflammatory response induced by gliadins in intestinal epithelial cells via modifications of toxic peptide generation during digestion. J Cell Biochem 109(4):801–807PubMed

73.

Laparra JM, Olivares M, Gallina O, Sanz Y (2012) Bifidobacterium longum CECT 7347 modulates immune responses in a gliadin-induced enteropathy animal model. PLoS One 7(2):e30744PubMedPubMedCentralCrossRef

74.

Sánchez E, Laparra JM, Sanz Y (2012) Discerning the role of Bacteroides fragilis in celiac disease pathogenesis. Appl Environ Microbiol 78(18):6507–6515PubMedPubMedCentralCrossRef

75.

Kolho KL, Korpela K, Jaakkola T, Pichai MVA, Zoetendal EG, Salonen A, Vos WMD (2015) Fecal microbiota in pediatric inflammatory bowel disease and its relation to inflammation. Am J Gastroenterol 110(6):921PubMedCrossRef

76.

Lucke K, Miehlke S, Jacobs E, Schuppler M (2006) Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis. J Med Microbiol 55(5):617PubMedCrossRef

77.

Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C, Rostron T, Cerundolo V, Pamer EG, Abramson SB (2013) Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife Sci 2(1629):e01202CrossRef

Titel: The combination of wheat peptides and fucoidan protects against chronic superficial gastritis and alters gut microbiota: a double-blinded, placebo-controlled study
verfasst von: Juntao Kan
Junrui Cheng
Leiming Xu
Molly Hood
Dingfu Zhong
Meijiao Cheng
Yumin Liu
Liang Chen
Jun Du
Publikationsdatum: 22.06.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nutrition / Ausgabe 4/2020
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-019-02020-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

The combination of wheat peptides and fucoidan protects against chronic superficial gastritis and alters gut microbiota: a double-blinded, placebo-controlled study

Abstract

Purpose

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2020

Modifying effect of metabotype on diet–diabetes associations

Association between grains, gluten and the risk of colorectal cancer in the Cancer Prevention Study-II Nutrition Cohort

Oral bovine colostrum supplementation does not increase circulating insulin-like growth factor-1 concentration in healthy adults: results from short- and long-term administration studies

Association between dietary insulin index and load with obesity in adults

The neuroprotective effect and action mechanism of polyphenols in diabetes mellitus-related cognitive dysfunction

Moderate chronic ethanol consumption exerts beneficial effects on nonalcoholic fatty liver in mice fed a high-fat diet: possible role of higher formation of triglycerides enriched in monounsaturated fatty acids

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin